Marina Konopleva m d ph d

Professor, Department of Leukemia, MD Anderson Cancer Center 

Location: United States

Consulting Services


Areas Of Interest

Acute Myeloid Leukemia Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia Apoptosis Cytarabine Myeloid Cells Bone Marrow

Professional Narrative

Konopleva is a Physician-Scientist, Professor, and active member of the clinical faculty in the Departments of Leukemia and Stem Cell Transplantation. Her laboratory is studying novel agents in acute myeloid and lymphocytic leukemias, focusing on BCL-2 targeting and agents targeting leukemic microenvironment and metabolism. Dr. Konopleva has extended her research to include clinical translational investigations and has developed clinical trials based on laboratory discoveries. These include BCL-2 inhibitor venetoclax, inhibitor of oxidative phosphorylation, CXCR4 inhibitors, AKT and mTOR inhibitors and hypoxia-activated prodrugs. She has also been an active mentor to trainees including undergraduate, medical and graduate students, post-doctoral fellows who have trained under her direction in support of her various laboratory grants and projects.

 


Employment


Education


Referees


Publications


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :